Univercell-biosolutions is developing human stem cells, cellular reprogramming and differentiation technologies to accelerate drug discovery and development with more informative and innovative human cell models. Univercell-Biosolutions has developed Mesopure® to provide a pure population of cardiovascular progenitors and thus for producing enriched mature and functional human cardiomyocytes (CM-ONE®) and human endothelium cells (ED-ONE®). We have also produced our Pluri-one Products in line with our Center of Expertise.